Olympiad Research’s Zimmer Biomet ZBH Stock Holding History

Olympiad Research’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,162	Closed	-$228K	–	382
2024 Q4	$228K	Buy	+2,162	New	+$232K	0.24%	161

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Olympiad Research's ZBH Position: Q1 2025 in Review

Olympiad Research sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,162 shares — an estimated $228K sold.

Olympiad Research first reported a position in ZBH in Q4 2024 and held it in 1 quarter. The position peaked at $228K in Q4 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

Olympiad Research reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
Olympiad Research sold 2,162 Zimmer Biomet shares in Q1 2025, an estimated $228K.
Olympiad Research first reported a position in Zimmer Biomet in Q4 2024 and held it in 1 quarter.
Olympiad Research's Zimmer Biomet position peaked at $228K in Q4 2024.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Olympiad Research's 13F filing for Q1 2025, filed 13 May 2025.